Table of contents

Clinical and epidemiological research

• Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis (14 July, 2008)

  C Lukas, R Landewé, J Sieper, M Dougados, J Davis, J Braun, S van der Linden, D van der Heijde, for the Assessment of SpondyloArthritis international Society
• Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials (18 January, 2008)

  C Salliot, M Dougados, L Gossec
• The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study (29 January, 2008)

  A Finckh, S Dehler, C Gabay
• Stress, coping strategies and social support in patients with primary Sjögren’s syndrome prior to disease onset: a retrospective case–control study (14 February, 2008)

  D Karaiskos, C P Mavragani, S Makaroni, E Zinzaras, M Voulgarelis, A Rabavilas, H M Moutsopoulos
• Sclerosing skin disorders in association with multiple sclerosis. Coincidence, underlying autoimmune pathology or interferon induced? (18 January, 2008)

  T Hügle, S Gratzl, T Daikeler, D Frey, A Tyndall, U A Walker
• Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol (4 February, 2008)

  M K Reinders, E N van Roon, T L Th A Jansen, J Delsing, E N Griep, M Hoekstra, M A F J van de Laar, J R B J Brouwers
• Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis? (21 February, 2008)

  S L Hider, A J Silman, W Thomson, M Lunt, D Bunn, D P M Symmons
• Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis (28 March, 2008)

  M G Perry, J R Kirwan, D S Jessop, L P Hunt
• Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

  (28 March, 2008)

  C Potter, K L Hyrich, A Tracey, M Lunt, D Plant, D P M Symmons, W Thomson, J Worthington, P Emery, A W Morgan, A G Wilson, J Isaacs, A Barton, BRAGGSS
• Contrast-enhanced ultrasound in monitoring the efficacy of a bradykinin receptor 2 antagonist in painful knee osteoarthritis compared with MRI (28 March, 2008)

  I H Song, C E Althoff, K G Hermann, A K Scheel, T Knetsch, G R Burmester, M Backhaus
• Pathological features of temporal arteries in patients with giant cell arteritis presenting with permanent visual loss (5 February, 2008)

  D Chatelain, P Duhaut, J Schmidt, R Loire, S Bosshard, M Guernou, H Pellet, J C Piette, H Sevestre, J P Ducroix
• Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders (28 March, 2008)

  B Terrier, D Sène, D Saadoun, P Ghillani-Dalbin, V Thibault, A Delluc, J-C Piette, P Cacoub
• Autologous stem cell transplantation improves microcirculation in systemic sclerosis (28 February, 2008)

  I Miniati, S Guiducci, M L Conforti, V Rogai, G Fiori, M Cinelli, R Saccardi, S Guidi, A Bosi, A Tyndall, M Matucci-Cerinic
• Clinical subsequent fractures cluster in time after first fractures (3 August, 2008)

  T A C M van Geel, S van Helden, P P Geusens, B Winkens, G-J Dinant
• Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (29 July, 2008)

  P A Merkel, D D Cuthbertson, B Hellmich, G S Hoffman, D R W Jayne, C G M Kallenberg, J P Krischer, R Luqmani, A D Mahr, E L Matteson, U Specks, J H Stone, for the Vasculitis Clinical Research Consortium
• Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis (6 August, 2008)

  K A Guthrie, N R Tishkevich, J L Nelson